Remedent Market Cap

Remedent has a market cap or net worth of $192.73 thousand as of July 3, 2025. Its market cap has decreased by -95.00% in one year.

Market Cap

192.73K

Enterprise Value

n/a

Revenue

50.10K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.01

Market Cap Chart

Since October 22, 1998, Remedent's market cap has decreased from 207.16K to 192.73K, a decrease of -6.96%. That is a compound annual growth rate of -0.27%.

Market Cap History

Date	Market Cap	% Change
Jun 30, 2025	192.73K	-81.82%
Dec 18, 2024	1.06M	-43.30%
Dec 14, 2023	1.87M	-43.51%
Dec 23, 2022	3.31M	14.47%
Dec 31, 2020	2.89M	-10.18%
Dec 18, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 9, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.63B
Veradigm	823.67M
Nika Pharmaceuticals	708.22M
Elite Pharmaceuticals	640.84M
Tian'an Technology Group	628.15M
Glass House Brands	540.25M
American Oncology Network	443.39M
Northwest Biotherapeutics	363.62M

Market Cap Rankings